Research activities and perspectives in the production of medical radionuclides at SPES-LNL

by Gaia Pupillo (Istituto Nazionale di Fisica Nucleare)

Tuesday Mar 12, 2024, 3:00 PM → 5:00 PM Europe/Rome

Aula A (INFN and University of Torino)

Radionuclides and radiopharmaceuticals are fundamental tools in nuclear medicine, by enabling imaging and treatment in tens of millions of procedures performed worldwide on a yearly basis. In Europe, 9 millionpatients benefit from nuclear medicine procedures per year, including 1.5 million patients requiring radionuclide therapy against cancer. The production of medical radionuclides is thus a key aspect and emerging radionuclides are being playing a key role in the development of innovative radiopharmaceuticals. The availability of new research infrastructures dedicated to this goal is thus crucial for Europe. For such a reason, in 2021 the PRISMAP consortium was established as Horizon2020 call, to gather the European research community, first, working in this field. The INFN-LNL takes part in the PRISMAP consortium as an emerging facility, including both the direct activation method (LARAMED project, acronym for LAboratory of RAdioisotopes for MEDicine) and the ISOL (Isotope Separation On-Line) technique (ISOLPHARM project, acronym for ISOL technique for radioPHARMaceuticals), both based on the SPES infrastructure. The ongoing INFN research activities on medical radionuclides production using cyclotrons will be presented, as well as the future perspective of this interdisciplinary research field that presents a strong connection with the nuclear physics community.

 

Join Zoom Meeting https://infn-it.zoom.us/j/92570004612?pwd=RWZ5UkxUTHV0bG9LZVNXc2QwUmU4dz09

Meeting ID: 925 7000 4612 Passcode: 745875

LocandinaSeminari_Gaia Pupillo.pdf